UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bacterial ratchet motors

Proceedings of the National Academy of Sciences - PNAS, 2010-05, Vol.107 (21), p.9541-9545

2010

Volltextzugriff (PDF)

Violacein and biofilm production in Janthinobacterium lividum

Journal of applied microbiology, 2007-04, Vol.102 (4), p.992-999

2007

Volltextzugriff (PDF)

Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease

Gut, 2006-12, Vol.55 (12), p.1760-1767

2006

Volltextzugriff (PDF)

AB0112 Pathogenetic mechanisms in early rheumatoid arthritis: possible correlation between th17 and treg cells and gut microbiota structure: a pilot study

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1250

2018

Volltextzugriff (PDF)

Gut Microbiota and the Immune System: An Intimate Partnership in Health and Disease

International journal of immunopathology and pharmacology, 2012-10, Vol.25 (4), p.823-833

2012

Volltextzugriff (PDF)

Efficacy of acoustic waves in preventing Streptococcus mutans adhesion on dental unit water line

Annali di igiene, 2019-03, Vol.31 (2), p.109-116

2019

Volltextzugriff (PDF)

OC.10.3: Fecal Microbiota Transplantation Via Enema for Recurrent Clostridium Difficile Infection Modulates the Inflammatory Host Response and Restores Intestinal Dysbiosis

Digestive and liver disease, 2017-03, Vol.49, p.e103-e103

2017

Volltextzugriff (PDF)

P41 DOES THE GUT MICROBIOTA MODULATE THE INFLAMMATORY STATE IN CIRRHOTIC HOST?

Journal of hepatology, 2014-04, Vol.60 (1), p.S80-S80

2014

Volltextzugriff (PDF)

OP‐3 THE PROTECTIVE ROLE OF LACTOBACILLUS RHAMNOSUS GG‐DERIVED FACTORS AGAINST LPS‐INDUCED DAMAGE OF HUMAN COLONIC SMOOTH MUSCLE CELLS

Journal of pediatric gastroenterology and nutrition, 2015-10, Vol.61 (4), p.509-510

2015

Volltextzugriff (PDF)

Plasmid-mediated fluoroquinolone resistance determinants in Escherichia coli from community uncomplicated urinary tract infection in an area of high prevalence of quinolone resistance

European journal of clinical microbiology & infectious diseases, 2012-08, Vol.31 (8), p.1917-1921

2012

Volltextzugriff (PDF)

Does the gut microbiota modulate the inflammatory state in cirrhotic host?

Digestive and liver disease, 2014-02, Vol.46, p.e34-e34

2014

Volltextzugriff (PDF)

Gut Microbiota in HIV Infection : Implication for Disease Progression and Management

Gastroenterology research and practice, 2014-01, Vol.2014 (2014), p.1-6

2014

Volltextzugriff (PDF)

Conserved sequence motifs among bacterial, eukaryotic, and archaeal phosphatases that define a new phosphohydrolase superfamily

Protein science, 1998-07, Vol.7 (7), p.1647-1652

1998

Volltextzugriff (PDF)

117 Achromobacter xylosoxidans characteristics important for lung colonization of cystic fibrosis (CF) patients

Journal of cystic fibrosis, 2013-06, Vol.12, p.S78-S78

2013

Volltextzugriff (PDF)

PO36 CHARACTERIZATION OF MUCOSA-ASSOCIATED AND FECAL MICROBIOTA OF CHILDREN WITH AUSTISM SPECTRUM DISORDER

Digestive and liver disease, 2012-10, Vol.44, p.S273-S274

2012

Volltextzugriff (PDF)

WS3.3 Molecular characterization of fecal microbiota and metabolic profiles association in cystic fibrosis patients

Journal of cystic fibrosis, 2013-06, Vol.12, p.S5-S5

2013

Volltextzugriff (PDF)

WS8.3 Cystic fibrosis transmembrane conductance regulator ( CFTR ) allelic variants relate to shifts in fecal microbiota of cystic fibrosis patients

Journal of cystic fibrosis, 2013-06, Vol.12, p.S16-S16

2013

Volltextzugriff (PDF)

Bacterial nonspecific acid phosphohydrolases: physiology, evolution and use as tools in microbial biotechnology

Cellular and molecular life sciences : CMLS, 1998-08, Vol.54 (8), p.833-850

1998

Volltextzugriff (PDF)

T.01.4: PATIENTS WITH NONEROSIVE HEARTBURN AND EPIGATRIC PAIN SYNDROME (EPS) ARE NOT CLINICALLY DISTINGUISHABLE AND BENEFIT OF THE SAME TREATMENT. A RANDOMIZED CONTROLLED TRIAL (RCT) POST HOC ANALYSIS

Digestive and liver disease, 2024-04, Vol.56, p.S222-S223

2024

Volltextzugriff (PDF)

OC.15.5: POLIPROTECT IS AN EFFECTIVE TREATMENT TO MANAGE PPI DEPRESCRIBING. A RANDOMIZED CONTROLLED TRIAL (RCT) POST HOC ANALYSIS

Digestive and liver disease, 2024-04, Vol.56, p.S200-S200

2024

Volltextzugriff (PDF)

JC Viral Reactivation in a Pediatric Patient with Crohn's Disease

International journal of immunopathology and pharmacology, 2010-07, Vol.23 (3), p.955-959

2010

Volltextzugriff (PDF)

T.01.11 AN RC TRIAL COMPARING THE MUCOSAL PROTECTIVE AGENT (MPA) POLIPROTECT (NEOBIANACID®) (P) AND OMEPRAZOLE (O) IN THE TREATMENT OF HEARTBURN AND EPIGASTRIC PAIN/BURNING IN NON-EROSIVE REFLUX DISEASE (NERD) AND EPIGASTRIC PAIN SYNDROME (EPS)

Digestive and liver disease, 2023-03, Vol.55, p.S139-S139

2023

Volltextzugriff (PDF)

CO3 MICROBIOTA AND GENETIC ADAPTATION IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Digestive and liver disease, 2009, Vol.41, p.S200-S200

2009

Volltextzugriff (PDF)

OC.06.3 PROTECTIVE ACTIVITY OF LACTOBACILLUS RHAMNOSUS GG-DERIVED FACTORS ON PATHOGEN LIPOPOLYSACCHARIDE (LPS)-INDUCED DAMAGE OF HUMAN COLONIC SMOOTH MUSCLE CELLS

Digestive and liver disease, 2016-02, Vol.48, p.e91-e92

2016

Volltextzugriff (PDF)

Role of gut microbiota in the pathogenesis of celiac disease

Digestive and liver disease, 2008, Vol.40 (10), p.A42-A42

2008

Volltextzugriff (PDF)

1 – 25 von 254

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(222)
Mit Volltextzugriff
(214)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(149)
Life Sciences & Biomedicine
(109)
Physical Sciences
(63)
Humans
(57)
Microbiology
(36)
Biological And Medical Sciences
(32)
Microbiota
(27)
Mathematics
(25)
Female
(24)
Fundamental And Applied Biological Sciences. Psychology
(24)
Escherichia Coli
(22)
Male
(21)
Bacteria
(20)
Adult
(18)
Chemistry
(18)
Middle Aged
(18)
Food Science & Technology
(16)
Adolescent
(14)
Bacteriology
(14)
Chemistry, Applied
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Bacterial ratchet motors

Violacein and biofilm production in Janthinobacterium lividum

Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease

AB0112 Pathogenetic mechanisms in early rheumatoid arthritis: possible correlation between th17 and treg cells and gut microbiota structure: a pilot study

Gut Microbiota and the Immune System: An Intimate Partnership in Health and Disease

Efficacy of acoustic waves in preventing Streptococcus mutans adhesion on dental unit water line

OC.10.3: Fecal Microbiota Transplantation Via Enema for Recurrent Clostridium Difficile Infection Modulates the Inflammatory Host Response and Restores Intestinal Dysbiosis

P41 DOES THE GUT MICROBIOTA MODULATE THE INFLAMMATORY STATE IN CIRRHOTIC HOST?

OP‐3 THE PROTECTIVE ROLE OF LACTOBACILLUS RHAMNOSUS GG‐DERIVED FACTORS AGAINST LPS‐INDUCED DAMAGE OF HUMAN COLONIC SMOOTH MUSCLE CELLS

Plasmid-mediated fluoroquinolone resistance determinants in Escherichia coli from community uncomplicated urinary tract infection in an area of high prevalence of quinolone resistance

Does the gut microbiota modulate the inflammatory state in cirrhotic host?

Gut Microbiota in HIV Infection : Implication for Disease Progression and Management

Conserved sequence motifs among bacterial, eukaryotic, and archaeal phosphatases that define a new phosphohydrolase superfamily

117 Achromobacter xylosoxidans characteristics important for lung colonization of cystic fibrosis (CF) patients

PO36 CHARACTERIZATION OF MUCOSA-ASSOCIATED AND FECAL MICROBIOTA OF CHILDREN WITH AUSTISM SPECTRUM DISORDER

WS3.3 Molecular characterization of fecal microbiota and metabolic profiles association in cystic fibrosis patients

WS8.3 Cystic fibrosis transmembrane conductance regulator ( CFTR ) allelic variants relate to shifts in fecal microbiota of cystic fibrosis patients

Bacterial nonspecific acid phosphohydrolases: physiology, evolution and use as tools in microbial biotechnology

T.01.4: PATIENTS WITH NONEROSIVE HEARTBURN AND EPIGATRIC PAIN SYNDROME (EPS) ARE NOT CLINICALLY DISTINGUISHABLE AND BENEFIT OF THE SAME TREATMENT. A RANDOMIZED CONTROLLED TRIAL (RCT) POST HOC ANALYSIS

OC.15.5: POLIPROTECT IS AN EFFECTIVE TREATMENT TO MANAGE PPI DEPRESCRIBING. A RANDOMIZED CONTROLLED TRIAL (RCT) POST HOC ANALYSIS

JC Viral Reactivation in a Pediatric Patient with Crohn's Disease

T.01.11 AN RC TRIAL COMPARING THE MUCOSAL PROTECTIVE AGENT (MPA) POLIPROTECT (NEOBIANACID®) (P) AND OMEPRAZOLE (O) IN THE TREATMENT OF HEARTBURN AND EPIGASTRIC PAIN/BURNING IN NON-EROSIVE REFLUX DISEASE (NERD) AND EPIGASTRIC PAIN SYNDROME (EPS)

CO3 MICROBIOTA AND GENETIC ADAPTATION IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE

OC.06.3 PROTECTIVE ACTIVITY OF LACTOBACILLUS RHAMNOSUS GG-DERIVED FACTORS ON PATHOGEN LIPOPOLYSACCHARIDE (LPS)-INDUCED DAMAGE OF HUMAN COLONIC SMOOTH MUSCLE CELLS

Role of gut microbiota in the pathogenesis of celiac disease

Suchergebnisse filtern